Mirum Pharmaceuticals, Inc.
MIRM
Rank in Stocks
#3250
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Share Price
$83.62
Market Cap
$5.43B
Change (1 day)
-1.71%
Change (1 year)
21.22%
Country
US
Trade Mirum Pharmaceuticals, Inc. (MIRM)
Category
Healthcare
Stock price history for Mirum Pharmaceuticals, Inc. (MIRM)
Highest end of day price: $82.31 on 2026-10-01
Lowest end of day price: $13.66 on 2019-07-01
Lowest end of day price: $13.66 on 2019-07-01
Stock price history of Mirum Pharmaceuticals, Inc. from 2019 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 28.78% |
| 2025 | 68.24% |
| 2024 | 35.06% |
| 2023 | 73.09% |
| 2022 | 24.19% |
| 2021 | -29.47% |
| 2020 | 29.71% |
| 2019 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $137.75 | -3.72% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
